These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 10974635)
21. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin. Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878 [TBL] [Abstract][Full Text] [Related]
22. Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals. Song H; Wei M; Liu W; Shen S; Li J; Wang L Histol Histopathol; 2018 Jan; 33(1):73-79. PubMed ID: 28287251 [TBL] [Abstract][Full Text] [Related]
23. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity. Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666 [TBL] [Abstract][Full Text] [Related]
24. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer. Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876 [TBL] [Abstract][Full Text] [Related]
25. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines. Concin N; Stimpfl M; Zeillinger C; Wolff U; Hefler L; Sedlak J; Leodolter S; Zeillinger R Int J Oncol; 2003 Jan; 22(1):51-7. PubMed ID: 12469184 [TBL] [Abstract][Full Text] [Related]
26. UCN-01 in ovary cancer cells: effective as a single agent and in combination with cis-diamminedichloroplatinum(II)independent of p53 status. Husain A; Yan XJ; Rosales N; Aghajanian C; Schwartz GK; Spriggs DR Clin Cancer Res; 1997 Nov; 3(11):2089-97. PubMed ID: 9815601 [TBL] [Abstract][Full Text] [Related]
27. Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancer. Xiang J; Gómez-Navarro J; Arafat W; Liu B; Barker SD; Alvarez RD; Siegal GP; Curiel DT J Gene Med; 2000; 2(2):97-106. PubMed ID: 10809143 [TBL] [Abstract][Full Text] [Related]
28. Wild-type p53 gene transfection in human cultured sarcomas: effect of CDDP. Endo K; Kuratate I; Watanabe M; Yoshida H; Teshima R; Osaki M; Ito H Oncol Rep; 2001; 8(3):637-42. PubMed ID: 11295094 [TBL] [Abstract][Full Text] [Related]
29. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy. Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753 [TBL] [Abstract][Full Text] [Related]
30. Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function. Fraser M; Bai T; Tsang BK Int J Cancer; 2008 Feb; 122(3):534-46. PubMed ID: 17918180 [TBL] [Abstract][Full Text] [Related]
31. The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. Eliopoulos AG; Kerr DJ; Herod J; Hodgkins L; Krajewski S; Reed JC; Young LS Oncogene; 1995 Oct; 11(7):1217-28. PubMed ID: 7478541 [TBL] [Abstract][Full Text] [Related]
32. Mechanism of growth-inhibitory effect of cisplatin on human pancreatic cancer cells and status of p53 gene. Seki T; Ohba N; Makino R; Funatomi H; Mitamura K Anticancer Res; 2001; 21(3B):1919-24. PubMed ID: 11497278 [TBL] [Abstract][Full Text] [Related]
33. A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes. Cassinelli G; Supino R; Perego P; Polizzi D; Lanzi C; Pratesi G; Zunino F Int J Cancer; 2001 Jun; 92(5):738-47. PubMed ID: 11340581 [TBL] [Abstract][Full Text] [Related]
34. Synergistic effect of piperine and paclitaxel on cell fate via cyt-c, Bax/Bcl-2-caspase-3 pathway in ovarian adenocarcinomas SKOV-3 cells. Pal MK; Jaiswar SP; Srivastav AK; Goyal S; Dwivedi A; Verma A; Singh J; Pathak AK; Sankhwar PL; Ray RS Eur J Pharmacol; 2016 Nov; 791():751-762. PubMed ID: 27756602 [TBL] [Abstract][Full Text] [Related]
35. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status. Mirjolet JF; Barberi-Heyob M; Didelot C; Peyrat JP; Abecassis J; Millon R; Merlin JL Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365 [TBL] [Abstract][Full Text] [Related]
36. Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer. Coukos G; Makrigiannakis A; Kang EH; Rubin SC; Albelda SM; Molnar-Kimber KL Clin Cancer Res; 2000 Aug; 6(8):3342-53. PubMed ID: 10955822 [TBL] [Abstract][Full Text] [Related]
37. Taxol-induced bcl-2 phosphorylation in ovarian cancer cell monolayer and spheroids. Makhija S; Taylor DD; Gibb RK; Gerçel-Taylor C Int J Oncol; 1999 Mar; 14(3):515-21. PubMed ID: 10024685 [TBL] [Abstract][Full Text] [Related]
38. The association between p53 protein phosphorylation at serine 15, serine 20 and sensitivity of cells isolated from patients with ovarian cancer and cell lines to chemotherapy in in vitro study. Kamińska I; Bar JK Pharmacol Rep; 2018 Jun; 70(3):570-576. PubMed ID: 29684847 [TBL] [Abstract][Full Text] [Related]
39. Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines. Burger H; Nooter K; Boersma AW; Kortland CJ; Stoter G Br J Cancer; 1998 May; 77(10):1562-7. PubMed ID: 9635829 [TBL] [Abstract][Full Text] [Related]
40. The Effect of Thymoquinone on Apoptosis of SK-OV-3 Ovarian Cancer Cell by Regulation of Bcl-2 and Bax. Liu X; Dong J; Cai W; Pan Y; Li R; Li B Int J Gynecol Cancer; 2017 Oct; 27(8):1596-1601. PubMed ID: 28692636 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]